The biggest bottleneck in bringing new treatments to patients is the clinical trial. On average, getting a drug through the trial process takes nearly a decade & frequently costs $1B+. And the problem is only getting worse.
TrialSpark is a new healthcare company that owns the end-to-end drug development process. Our proprietary technology allows us to integrate & improve clinical research for patients, providers, & sponsors, while executing clinical trials faster & cheaper.